ABSTRACT
Introducción: La semaglutida es un fármaco que contribuye a la liberación de insulina por el páncreas y a la supresión del apetito por lo que lo convierte en un importante candidato para ser usado en el tratamiento de la diabesidad. Objetivo: Describir el efecto de la semaglutida en el tratamiento de las personas con diabesidad. Métodos: Se revisó la literatura publicada en el período comprendido de enero-febrero de 2021. Las palabras clave utilizadas fueron obesidad; diabetes mellitus; diabesidad; semaglutida; análogo del péptido similar al glucagón tipo 1. Se utilizaron como motores de búsqueda las bases de datos de Google Académico, PubMed y SciELO. Se evaluaron diferentes trabajos de revisión, investigación y páginas web que tenían menos de 10 años de publicados en idioma español, portugués o inglés, y que por el título trataban el tema de estudio. Fueron excluidos los artículos que no abordaron la relación entre diabetes y obesidad, así como el tratamiento con análogos del péptido similar al glucagón tipo 1. Esto permitió la consulta de 84 artículos, de los cuales 59 fueron referenciados. Conclusiones: El empleo de semaglutida favorece una mejor evolución en paciente con diabesidad, como complemento de una dieta y una actividad física adecuada. Al optimizar el control glucémico, contribuir a la pérdida de peso y a la mejoraría de ciertas comorbilidades, entre ellas la salud cardiovascular(AU)
Introduction: Semaglutide is a drug that contributes to the release of insulin from the pancreas and suppresses appetite, which makes it an important candidate for treating diabesity. Objective: To describe the role of semaglutide in the treatment of diabesity individuals. Methods: The necessary information to write this article was obtained in the 2022 two-month period January-February. The keywords used were obesity; Mellitus diabetes; diabesity; semaglutide; type 1 glucagon-like peptide analogue. The search engines corresponding to the Google Scholar, PubMed and SciElO databases were used. Different review, research and web pages were evaluated, which in general were published no more than 10 years ago, in Spanish, Portuguese or English and which dealt with the subject of study by title. Articles that did not address the relationship between diabetes and obesity, as well as treatment with glucagon-like peptide 1 analogues, were excluded. This allowed the consultation of 84 articles, 59 of them were referenced. Conclusions: The use of semaglutide, as a complement to a diet and physical activity appropriate to the needs of patients with diabesity, brought about several effects that favor better evolution of this health problem, by optimizing glycemic control, contributing to the loss of weight and the improvement of certain comorbidities, including cardiovascular health(AU)
Subject(s)
Humans , Male , Female , Diabetes Mellitus/epidemiology , Glucagon-Like Peptide-1 Receptor , Obesity/epidemiologyABSTRACT
Type 2 Diabetes occurring in the context of obesity is a term called diabesity， of which clinical outcome is more serious and complicated. Metaflammation is the main reason that causes insulin resistance and eventually leads to diabesity development. In this review， the author discusses the initiating factors that triggers metaflammation， and how this drives insulin resistance. This review also demonstrates our current work on pathogenesis of diabesity from the perspective of “gut microbiota-immune-metabolic axis”， as well as exploring effective treatments for diabesity through combination of body weight and glycemic control. In the end， the review briefly summarizes the "3+N" model for the treatment of diabesity and its complications from a multidisciplinary team （MDT） of the Third Affiliated Hospital of Sun Yat-sen University， providing one-stop comprehensive management services for patients.
ABSTRACT
ABSTRACT Introduction: Diabesity is characterized as a simultaneous condition of type 02 diabetes and obesity. Among the aspects that influence the development of diabetes, the time in sedentary behavior and the time of physical activity are important risk factors. Objectives: To estimate cut-off points for time spent in sedentary behavior and physical activity as a discriminator of the presence of diabesity and to evaluate the predictive ability of WC and PA to identify this condition in quilombola adults. Methodology: this is a cross-sectional study with a sample composed of 332 adults (age ≥ 50 years), participants in the study of the Epidemiological Profile of Quilombolas from Bahia living in the micro-region of Guanambi, Brazil. The data were obtained by means of interviews and anthropometric evaluation. Sociodemographic and lifestyle information (physical activity and sedentary behavior) were included. To analyze the cut-off point of Sedentary Behavior as a predictor of diabesity, the Receiver Operating Characteristic (ROC) curve was used. Results: Time in sedentary behavior >120 min/day and time in physical activity <240 min/week were the best cut-off points for discriminating diabesity in quilombola, with area under the ROC curve of 0.62, 95% CI (0.56-0.67) and 0.62 (95% CI: 0.55-0.67), respectively. Conclusions: The results showed that time in sedentary behavior and time in physical activity showed a good ability to discriminate the presence of diabesity among quilombola adults.
RESUMO Introdução: A Diabesidade caracteriza-se como uma condição simultânea de diabetes tipo 02 e obesidade. Dentre os aspectos que influenciam o desenvolvimento da diabesidade, o tempo em comportamento sedentário e o tempo de atividade física apresentam-se como importantes fatores de risco. Objetivos: estimar pontos de corte para o tempo em comportamento sedentário e atividade física como discriminador de presença de diabesidade e avaliar a capacidade preditiva do CS e AF para identificar essa condição em adultos quilombolas. Metodologia: trata-se de estudo transversal com amostra composta por 332 adultos (idade ≥ 50 anos), participantes do estudo de Perfil Epidemiológico dos Quilombolas baianos residentes na microrregião de Guanambi, Brasil. Os dados foram obtidos por meio de entrevistas e avaliação antropométrica. Foram incluídas informações sociodemográficas e estilo de vida (atividade física e comportamento sedentário). Para a análise do ponto de corte do Comportamento Sedentário e o tempo de atividade física como preditores de diabesidade, foi utilizada a curva Receiver Opereting Characteristic (ROC). Resultados: Tempo em comportamento sedentário >120 min/dia e tempo de atividade física >240 min/semana foram os melhores pontos de corte para discriminar a diabesidade em quilombola, com área sob a curva ROC de 0,62, IC 95% (0,56-0,67) e 0,62 (IC 95%: 0,55-0,67), respectivamente. Conclusões: Os resultados mostraram que o tempo em comportamento sedentário e atividade física apresentaram uma boa capacidade para discriminar a presença de diabesidade entre adultos quilombolas.
ABSTRACT
El empleo de la cirugía metabólica, como tratamiento capaz de revertir o mejorar la diabesidad, ha llamado la atención por las transformaciones inducidas en los pacientes sometidos a esta intervención. Esas transformaciones se tratan de explicar a través de los cambios anatómicos y fisiológicos que la intervención produce. Un mayor conocimiento de las teorías y los mecanismos que garantizan la pérdida de peso y una mejor respuesta metabólica puede contribuir al diseño de estrategias más efectivas. El objetivo es describir las teorías y mecanismos que tratan de explicar los cambios benéficos observados después de una cirugía metabólica en personas con diabesidad. Se utilizó como buscador de información científica Google Académico. Se emplearon como palabras clave: cirugía bariátrica, cirugía metabólica, obesidad, diabetes mellitus tipo 2 y diabesidad. Fueron evaluados artículos de revisión y de investigación en idioma español, portugués o inglés que tenían menos de 10 años de publicados, provenientes de diferentes bases de datos: PubMed, LILACS, Cochrane y SciElo y páginas web en general. Esto permitió el estudio de 110 artículos, de los cuales, 66 fueron referenciados. Los cambios inducidos por la cirugía metabólica y sus resultados en personas con diabesidad se han relacionado con diferentes teorías y mecanismos: teoría del intestino proximal y del intestino distal, por ejemplo. A lo anterior se suman los cambios en la microbiota intestinal y la mayor disponibilidad de ácidos biliares en el íleon. Las diferentes teorías se complementan entre sí y es difícil poder establecer cuál de ellas resulta de mayor utilidad, lo que también depende de la técnica quirúrgica empleada (restrictiva o restrictiva malabsortiva) y de sus mecanismos de acción(AU)
The use of metabolic surgery as a treatment capable of either reverting or improving diabesity has attracted attention due to the transformations induced in patients undergoing such intervention. These transformations have been attributed to the anatomical and physiological changes brought about by the surgery. Enriched knowledge about the theories and mechanisms ensuring weight loss and a better metabolic response may contribute to the design of more effective strategies. The objective is to describe the theories and mechanisms which intend to explain the beneficial changes observed after metabolic surgery in people with diabesity. Scientific information was obtained from the search engine Google Scholar using the key words bariatric surgery, metabolic surgery, obesity, type 2 diabetes mellitus and diabesity. Evaluation was conducted of review and research papers published in Spanish, Portuguese or English in the past 10 years on various databases (PubMed, LILACS, Cochrane, SciELO) and webpages. A total 110 papers were analyzed of which 66 were referenced. Changes induced by metabolic surgery and their results in people with diabesity have been associated to different theories and mechanisms, e.g. the proximal intestine hypothesis and the distal intestine hypothesis. To this are added the changes in the intestinal microbiota and a greater availability of bile acids in the ileum. The different theories complement one another, and it is hard to decide which is the most useful, for it also depends on the surgical technique used (restrictive or malabsorptive restrictive) and its mechanisms of action(AU)
Subject(s)
Humans , Review Literature as Topic , Databases, Bibliographic/statistics & numerical data , Diabetes Mellitus, Type 2/drug therapy , Bariatric Surgery/adverse effects , Obesity/prevention & control , Body Mass IndexABSTRACT
Aim: Obesity and family history of Type 2 Diabetes mellitus are the major risk factors for the development of type 2 Diabetes mellitus in youth. The purpose of this study is to investigate the association between serum ferritin and insulin resistance in healthy young obese with and without family history of type 2 Diabetes mellitus. Place and Duration of Study: Department of Biochemistry, Rajarajeswari Medical College and Hospital, Kambipura, Bangalore, Karnataka, India, for eight months period in the year 2012. Material and Methods: A small group study was undertaken in 90 students who were in the age group of 17-22 years. The study population was divided into two groups based on body mass index, Group I /non-obese group (n=46) and Group II/ overweight & obese group (n=44). Fasting and postprandial blood glucose, Serum ferritin, serum insulin and lipid parameters were estimated and Homeostasis Model Assessment-Insulin resistance (HOMA-IR) was calculated for all the ninety students. Results: Statistically significant differences in Total cholesterol (p=0.05), Triglycerides (p=0.05), serum insulin (p<0.01) and HOMA (p<0.01) were observed between the two groups. Mean serum ferritin values were increased in group II (overweight/obese) but not statistically significant. Serum insulin and serum ferritin showed a significant correlation with BMI for the whole study group. Serum ferritin and insulin levels significantly correlated with waist to hip ratio in students with family history of Type 2 Diabetes mellitus as against individuals without family history. 59% of the obese students with family history of Diabetes mellitus had insulin resistance. Conclusion: Our study has shown that a significant proportion of obese students with family history of type 2 diabetes mellitus had insulin resistance and elevated levels of ferritin, highlighting the importance of early screening for obesity associated co morbidities like metabolic syndrome, Type 2 Diabetes mellitus and cardiovascular diseases in these individuals
ABSTRACT
With an increase in the instances of obesity, the cases of type 2 diabetes, which is caused by obesity, have also increased significantly. Because of this, the number of obesity metabolic operations performed on diabetes patients with obesity is also accumulating, and there has been no concern for implementing approaches to psychological support for these patients. Negative psychologies include anxiety, depression, passive attitude, stress, fear and impulse control disorder, which continuously influence the patient in a vicious circle of recurrence of obesity and diabetes, even after the obesity metabolic operation was attempted. Therefore, for the success of the obesity metabolic operation and the continuation of self-management of obesity and diabetes post-operation, psychological support is very important. Post-operative psychological support approaches include a respiration method, autogenic training, self-expression training, a stress reduction program, thought-change training and communication skills.
Subject(s)
Humans , Anxiety , Autogenic Training , Depression , Obesity , Recurrence , Respiration , Self CareABSTRACT
Currently, metabolic surgery (Laparoscopic Roux-en-Y gastric bypass, LRYGB) has an important role and should be recommended as an intervention in the management of obese patients with type 2 diabetes mellitus (T2DM). A successful outcome of surgery requires medical nutrition therapy. Therefore, we performed a retrospective study on 25 patients with T2DM who underwent LRYGB at Yeouido St. Mary's Hospital from October 2008 to May 2010. The patients were followed up for an average of 6 months after surgery (range: 2~19 months). Diabetes was resolved in 80% of the patients. Percentage of excess weight loss was (%EWL) was 56.2%. After surgery, fasting blood sugar (FBS) and HbA1c were significantly reduced (123 mg/dl, A1c 6.7%, P<0.001) and triglyceride was also significantly reduced to 107.6 mg/dl (P<0.05). As diets of the patients progressed from liquid to soft to regular diet, energy, carbohydrates, and fat intakes increased significantly (P<0.001). But protein intake did not change significantly. Nutrient intake of the patients after the surgery was significantly lower than the recommended diet for the non-surgery group. Patients experienced side-effects related to the diets after surgery, including hair-loss (76%), smelly gas (52%), vomiting (48%), etc. A significantly positive correlation was observed between vomiting and FBS (P<0.001). There was a significant relationship between side effects and the amount of nutrient intakes. Therefore, guide patients to a diet progression with treatment to minimize side effects, especially vomiting. And monitor their dietary life to be healthy and not to regain weight until remission of T2DM.